This inventor holds 1 USPTO granted patent. Top assignees: Carnegie Institution of Washington, Johns Hopkins University. Active years: 2020.
Company Filing History:
1 out of 89 
1 out of 3,794 
Years Active: 2020
Title: The Innovative Contributions of James H. Thierer
Introduction
James H. Thierer is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of biotechnology, particularly in the development of screening methods for drug discovery. His work focuses on understanding the modulation of Apolipoprotein B, which plays a crucial role in lipid metabolism and cardiovascular health.
Latest Patents
Thierer holds a patent for a "High-throughput, in vivo screening platform for modulators of Apolipoprotein B." This innovative method describes a high-throughput, phenotypic screening technique utilizing larval zebrafish to identify modulators of ApoB expression. The modulators can be either enhancers or inhibitors, providing a unique opportunity to explore drug targets across various cell and tissue types in a whole organism. This approach maximizes the potential for discovering viable pre-therapeutic leads for compounds or biologics applicable to human health.
Career Highlights
Throughout his career, Thierer has been associated with prestigious institutions such as Johns Hopkins University and the Carnegie Institution of Washington. His work has significantly advanced the understanding of lipid metabolism and its implications for health and disease.
Collaborations
Thierer has collaborated with notable professionals in his field, including Steven A. Farber. Their joint efforts have contributed to the advancement of research in drug discovery and biotechnology.
Conclusion
James H. Thierer is a prominent inventor whose work in high-throughput screening methods has the potential to revolutionize drug discovery processes. His contributions to understanding Apolipoprotein B modulation are invaluable in the quest for effective therapeutic solutions.